InvestorsHub Logo
Followers 28
Posts 1178
Boards Moderated 0
Alias Born 08/31/2009

Re: Canoepaddler post# 2915

Thursday, 04/03/2014 1:37:52 PM

Thursday, April 03, 2014 1:37:52 PM

Post# of 8439
Long term this company has great things outside of Trimesta so the degree of risk is minimized.

Seel made a point and maybe it was on the board but regardless of positive or negative results for Trimesta they will be discussed in order advance scientific discovery. I do agree that one cannot predict results will be positive and this is a very stringent trial design so that makes it tougher to say one way or the other. Just based on patient type and results in earlier study's with this patient type I feel good about what will be released. But that is just my opinion and I'm not a statician nor am I claiming to be an expert on looking at clinical studies.

At any rate long term I will be good due to the pipeline in development and that allows me more confidence to see the results laid out for Trimesta.

Dr V will be presenting top line data in one presentation and in another presentation she will discuss the MOA of Trimesta. There will be a great deal of info to look at...

GLTE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News